The following is from MedPage Today. Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean follow-up of […]
The following is from Reuters. BERLIN, Oct 24 – Several people were hospitalised in Austria after using suspected fake versions of Novo Nordisk’s diabetes drug Ozempic, the country’s health safety body said, the first report of harm to users as
The following is an excerpt from The Vaccine Reaction. Just two months after the European Medicines Agency (EMA) issued a safety signal citing concerns about a possible link to all types of thyroid cancer in people using Ozempic, doctors are
Popular weight-loss drugs now linked to stomach paralysis, suicide Read More »
The following is an excerpt from The Vaccine Reaction. New weight loss drug Ozempic has taken the world’s obesity epidemic by storm, but like most weight loss drugs that precede it over the past century, shedding extra pounds may not
More safety questions, incl. thyroid cancer, re: Ozempic for weight loss Read More »
The following is from The Defender. The latest weight loss craze to hit Hollywood and beyond is semaglutide, more popularly known as Ozempic, the brand name of the drug marketed to improve blood sugar in people with Type 2 diabetes. Semaglutide
The FDA has approved a new, under-the-skin injection called semaglutide for weight loss. That’s according to Medscape. Semaglutide induces weight loss by reducing hunger, increasing feelings of fullness, and thereby helping people eat less and reduce their calorie intake Novo
(READ) FDA approves new, weekly weight loss drug Read More »
